|
|
|
12.07.26 - 19:06
|
Ascelia Pharma Provides Orviglance Update (Accesswire)
|
|
|
MALMÖ, SE / ACCESS Newswire / July 12, 2026 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (STO:ACE), a biopharmaceutical company focused on improving the lives of people living with rare ca......
|
|
|
|
|
|
|
11.07.26 - 19:48
|
Altersvorsorge: Blick nach Schweden (FAZ)
|
|
|
Wenn die Bundesregierung die Kapitalrente einführt, muss sie sich aus der Geldanlage heraushalten. Damit sind die Bürger in Schweden fast drei Jahrzehnte gut gefahren....
|
|
|
11.07.26 - 18:06
|
Correction regarding previous press release: Missing MAR statement (Cision)
|
|
|
BiBBInstruments AB ("BiBB" or the "Company") is issuing a correction to the press release regarding an exclusive distribution agreement with Palex Medical Spain, published on July 9, 2026. The correction relates solely to the inclusion of the MAR statement pursuant to the EU Market Abuse Regulation (MAR). Apart from this, the press release remains unchanged. The Swedish version of the press release included the MAR statement and was published correctly.
The corrected version of the press release follows below.
BiBB signs exclusive distribution agreement with Palex Medical Spain...
|
|
|
|
|
|
|
10.07.26 - 16:01
|
CEOTRONICS Aktie: Peer Group-Analyse - CEOTRONICS im internationalen Wettbewerb (Aktiencheck)
|
|
|
Hamburg (www.aktiencheck.de) - CEOTRONICS-Aktienanalyse der Montega AG:
Bastian Brach, Analyst der Montega AG, rät in einer aktuellen Aktienanalyse weiterhin zum Kauf der Aktie der CEOTRONICS AG (ISIN: DE0005407407, WKN: 540740, Ticker-Symbol: CEK).
Mit dem Börsengang von Savox existiere neben INVISIO erstmals eine breitere börsennotierte Peer Group für Anbieter taktischer Kommunikationssysteme. [mehr]...
|
|
|
10.07.26 - 14:18
|
HennesMauritz AB (HM, H&M) Underperform (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für H&M mit einem Kursziel von 130 schwedischen Kronen auf "Underperform"belassen. Die größten europäischen Handelsmarken verlören an Relevanz und büßten Marktanteile ......
|
|
|
10.07.26 - 13:48
|
Buy-back of shares in Corem 6–9 July 2026 (Cision)
|
|
|
Corem Property Group AB (publ) (LEI code: 213800CHXQQD7TSS1T59) ("Corem") has during 6-9 July 2026 repurchased in total 3,300,000 own ordinary shares of Class B, 4,900 own ordinary shares of Class D and 4,509 own preference shares as part of the two parallel share buy-back programs which were initiated by the board of directors of Corem and announced by Corem on 27 April 2026, (“Share buy-back program”) and (“Share buy-back Safe Harbour”).
The Safe Harbour share buyback program is thereby terminated, in accordance with the communicated end date 9 July 2026. The Safe Harbour share buy-...
|
|
|
|
|
10.07.26 - 13:30
|
Invitation to presentation in connection with EQL Pharma′s interim report, first quarter, 2026/27 (Cision)
|
|
|
EQL Pharma AB (publ) will publish its interim report for the first quarter, 2026/27, on Friday, 7[th ]August.
At 10.00 (CET) 7[th] August, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the interim report. After the presentation, there is an opportunity to ask questions for those who participate.
Use the following link to access the virtual meeting: https://tinyurl.com/nj5tmxzh
Date and time
August 7[th], 2026, at 10.00 (CET) the presentation...
|
|
|
|
|
|
|
10.07.26 - 12:01
|
Invitation to the presentation of Skanska′s interim report second quarter 2026 on July 17 (Cision)
|
|
|
Skanska's interim report second quarter 2026 will be released on Friday July 17 at 07:30 am CEST.
The report will be presented by Anders Danielsson, Skanska's President and CEO, and Pontus Winqvist, CFO, at a telephone conference at 10:00 am. The telephone conference will be webcasted live at www.skanska.com/group/en/investors, where it also will be posted shortly afterwards.
Participate in the telephone conference, with the opportunity to ask questions: Please join via any of these telephone numbers.
· +46 (0)8 5051 0031
· +44 (0) 203 059 58 63
· +1 (1) 631 570 56 13...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
